Eurofins Scientific SE (ERF.PA)
EUR 50.44
(-3.45%)
EUR 50.44
(-3.45%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.17 Billion EUR | 47.16% |
| 2022 | 2.83 Billion EUR | 26.8% |
| 2021 | 2.23 Billion EUR | -0.16% |
| 2020 | 2.24 Billion EUR | -30.89% |
| 2019 | 3.24 Billion EUR | 22.4% |
| 2018 | 2.65 Billion EUR | 89.9% |
| 2017 | 1.39 Billion EUR | 150.27% |
| 2016 | 557.78 Million EUR | -39.13% |
| 2015 | 916.27 Million EUR | 85.63% |
| 2014 | 493.61 Million EUR | 27.6% |
| 2013 | 386.84 Million EUR | 28.59% |
| 2012 | 300.83 Million EUR | 17.89% |
| 2011 | 255.18 Million EUR | 50.81% |
| 2010 | 169.21 Million EUR | 157.72% |
| 2009 | 65.65 Million EUR | -58.46% |
| 2008 | 158.07 Million EUR | 658.75% |
| 2007 | -28.29 Million EUR | -32.75% |
| 2006 | -21.31 Million EUR | -135.38% |
| 2005 | 60.23 Million EUR | 120.12% |
| 2004 | 27.36 Million EUR | -45.0% |
| 2003 | 49.75 Million EUR | -8.56% |
| 2002 | 54.4 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 2.71 Billion EUR | -34.99% |
| 2024 Q2 | 2.71 Billion EUR | 0.0% |
| 2023 Q2 | 2.58 Billion EUR | 5.37% |
| 2023 Q3 | 2.56 Billion EUR | -0.98% |
| 2023 FY | 4.17 Billion EUR | 47.16% |
| 2023 Q4 | 4.17 Billion EUR | 63.01% |
| 2023 Q1 | 2.45 Billion EUR | -13.48% |
| 2022 Q2 | 2.62 Billion EUR | 5.15% |
| 2022 Q1 | 2.49 Billion EUR | 11.6% |
| 2022 FY | 2.83 Billion EUR | 26.8% |
| 2022 Q4 | 2.83 Billion EUR | 4.74% |
| 2022 Q3 | 2.71 Billion EUR | 3.17% |
| 2021 Q4 | 2.23 Billion EUR | 5.7% |
| 2021 Q3 | 2.11 Billion EUR | 5.11% |
| 2021 FY | 2.23 Billion EUR | -0.16% |
| 2021 Q2 | 2.01 Billion EUR | 0.0% |
| 2021 Q1 | 2.01 Billion EUR | -10.13% |
| 2020 Q4 | 2.24 Billion EUR | 5.59% |
| 2020 Q3 | 2.12 Billion EUR | -17.82% |
| 2020 FY | 2.24 Billion EUR | -30.89% |
| 2020 Q1 | 2.58 Billion EUR | -20.36% |
| 2020 Q2 | 2.58 Billion EUR | 0.0% |
| 2019 Q2 | 3.24 Billion EUR | 0.0% |
| 2019 Q3 | 3.11 Billion EUR | -3.85% |
| 2019 Q1 | 3.24 Billion EUR | 22.27% |
| 2019 FY | 3.24 Billion EUR | 22.4% |
| 2019 Q4 | 3.24 Billion EUR | 4.11% |
| 2018 Q4 | 2.65 Billion EUR | 0.35% |
| 2018 FY | 2.65 Billion EUR | 89.9% |
| 2018 Q1 | 1.63 Billion EUR | 17.4% |
| 2018 Q2 | 1.63 Billion EUR | 0.0% |
| 2018 Q3 | 2.64 Billion EUR | 61.19% |
| 2017 Q4 | 1.39 Billion EUR | 0.46% |
| 2017 Q3 | 1.38 Billion EUR | 83.16% |
| 2017 Q2 | 758.67 Million EUR | -0.06% |
| 2017 FY | 1.39 Billion EUR | 150.27% |
| 2017 Q1 | 759.1 Million EUR | 36.09% |
| 2016 Q4 | 557.78 Million EUR | 0.73% |
| 2016 Q2 | 817.33 Million EUR | -0.37% |
| 2016 Q1 | 820.35 Million EUR | -10.47% |
| 2016 FY | 557.78 Million EUR | -39.13% |
| 2016 Q3 | 553.71 Million EUR | -32.25% |
| 2015 FY | 916.27 Million EUR | 85.63% |
| 2015 Q4 | 916.27 Million EUR | -0.04% |
| 2015 Q3 | 916.61 Million EUR | 132.64% |
| 2015 Q2 | 394 Million EUR | -2.3% |
| 2015 Q1 | 403.27 Million EUR | -18.3% |
| 2014 Q2 | 485.73 Million EUR | -2.92% |
| 2014 Q3 | 503.12 Million EUR | 3.58% |
| 2014 Q4 | 493.61 Million EUR | -1.89% |
| 2014 FY | 493.61 Million EUR | 27.6% |
| 2014 Q1 | 500.34 Million EUR | 29.34% |
| 2013 Q1 | 397.61 Million EUR | 32.17% |
| 2013 Q2 | 381.51 Million EUR | -4.05% |
| 2013 Q4 | 386.84 Million EUR | -2.76% |
| 2013 Q3 | 397.81 Million EUR | 4.27% |
| 2013 FY | 386.84 Million EUR | 28.59% |
| 2012 Q2 | 310.6 Million EUR | 312.99% |
| 2012 FY | 300.83 Million EUR | 17.89% |
| 2012 Q3 | -25.5 Million EUR | -108.21% |
| 2012 Q4 | 300.83 Million EUR | 1279.7% |
| 2012 Q1 | 75.2 Million EUR | -70.53% |
| 2011 Q3 | 258.2 Million EUR | -4.77% |
| 2011 Q1 | 130.37 Million EUR | -22.95% |
| 2011 Q2 | 271.14 Million EUR | 107.97% |
| 2011 Q4 | 255.18 Million EUR | -1.17% |
| 2011 FY | 255.18 Million EUR | 50.81% |
| 2010 Q2 | -23.64 Million EUR | -112.75% |
| 2010 FY | 169.21 Million EUR | 157.72% |
| 2010 Q3 | 197 Million EUR | 933.31% |
| 2010 Q4 | 169.21 Million EUR | -14.11% |
| 2010 Q1 | 185.38 Million EUR | 182.35% |
| 2009 FY | 65.65 Million EUR | -58.46% |
| 2009 Q4 | 65.65 Million EUR | 300.0% |
| 2009 Q2 | 16.41 Million EUR | 0.0% |
| 2009 Q1 | 16.41 Million EUR | -58.46% |
| 2009 Q3 | 16.41 Million EUR | 0.0% |
| 2008 Q4 | 39.51 Million EUR | 0.0% |
| 2008 Q1 | 39.51 Million EUR | 658.75% |
| 2008 Q3 | 39.51 Million EUR | 0.0% |
| 2008 FY | 158.07 Million EUR | 658.75% |
| 2008 Q2 | 39.51 Million EUR | 0.0% |
| 2007 Q3 | -7.07 Million EUR | 0.0% |
| 2007 Q2 | -7.07 Million EUR | 0.0% |
| 2007 Q4 | -7.07 Million EUR | 0.0% |
| 2007 Q1 | -7.07 Million EUR | -32.75% |
| 2007 FY | -28.29 Million EUR | -32.75% |
| 2006 Q4 | -5.32 Million EUR | 0.0% |
| 2006 Q3 | -5.32 Million EUR | 0.0% |
| 2006 Q2 | -5.32 Million EUR | 0.0% |
| 2006 FY | -21.31 Million EUR | -135.38% |
| 2006 Q1 | -5.32 Million EUR | -135.38% |
| 2005 Q4 | 15.05 Million EUR | 0.0% |
| 2005 Q3 | 15.05 Million EUR | 0.0% |
| 2005 Q2 | 15.05 Million EUR | 0.0% |
| 2005 Q1 | 15.05 Million EUR | 120.12% |
| 2005 FY | 60.23 Million EUR | 120.12% |
| 2004 Q3 | 6.84 Million EUR | 0.0% |
| 2004 Q4 | 6.84 Million EUR | 0.0% |
| 2004 Q2 | 6.84 Million EUR | 0.0% |
| 2004 Q1 | 6.84 Million EUR | -40.48% |
| 2004 FY | 27.36 Million EUR | -45.0% |
| 2003 Q3 | 11.49 Million EUR | 0.0% |
| 2003 Q4 | 11.49 Million EUR | 0.0% |
| 2003 FY | 49.75 Million EUR | -8.56% |
| 2003 Q2 | 11.49 Million EUR | 0.0% |
| 2003 Q1 | 11.49 Million EUR | -10.69% |
| 2002 Q1 | 12.86 Million EUR | 0.0% |
| 2002 Q4 | 12.86 Million EUR | 0.0% |
| 2002 FY | 54.4 Million EUR | 0.0% |
| 2002 Q3 | 12.86 Million EUR | 0.0% |
| 2002 Q2 | 12.86 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Biosynex SA | 45.43 Million EUR | -9095.686% |
| Predilife S.A. | 4.67 Million EUR | -89318.019% |
| bioMérieux S.A. | 166.39 Million EUR | -2410.577% |
| Lumibird SA | 88.88 Million EUR | -4600.164% |